Dr. Christopher French, MD, PHD
What this data tells you about Dr. French
Dr. Christopher French is a cardiovascular disease in Greenville, TX, with 14 years in practice. Based on federal Medicare data, Dr. French performed 5,736 Medicare services across 3,729 unique beneficiaries.
Between the years covered by Open Payments, Dr. French received a total of $246 from 6 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. French is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,190 | $85 | $238 |
| Anticoagulant management of patient taking warfarin | 617 | $8 | $41 |
| Regadenoson injection (Lexiscan) for heart stress test | 604 | $45 | $203 |
| Electrocardiogram (EKG), 12-lead | 565 | $9 | $51 |
| Echocardiogram, transthoracic | 482 | $137 | $726 |
| Hospital follow-up visit, moderate complexity | 412 | $60 | $186 |
| Heart muscle strain imaging | 410 | $27 | $139 |
| Prothrombin time test (blood clotting) | 317 | $4 | $26 |
| Initial hospital admission, moderate complexity | 160 | $96 | $352 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 156 | $53 | $522 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 149 | $330 | $1,599 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 149 | $47 | $258 |
| New patient office visit (45-59 min) | 128 | $102 | $310 |
| Hospital follow-up visit, high complexity | 77 | $89 | $268 |
| Ultrasound of both sides of head and neck blood flow | 74 | $140 | $704 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 69 | $19 | $130 |
| Office visit, established patient (20-29 min) | 38 | $62 | $168 |
| Telephone medical discussion with physician, 5-10 minutes | 34 | $32 | $131 |
| Initial hospital admission, high complexity | 33 | $130 | $517 |
| Electrocardiogram (ecg) 2-day continuous | 17 | $14 | $105 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $118 | $858 |
| Blood draw (venipuncture) | 15 | $8 | $17 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $129 | $692 |
| Ultrasound of leg arteries or artery grafts | 12 | $182 | $891 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. French is a clinical cardiology specialist, with above-average Medicare volume (top 12% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. French experienced with office visit, established patient (30-39 min)?
Does Dr. French receive payments from pharmaceutical companies?
How do Dr. French's costs compare to other cardiovascular diseases in Greenville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology